Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Beth A. Carella"'
Autor:
Katie Bergstrom, Yigal Dror, Kathleen Overholt, Melissa J. Rose, Paul Castillo, Beth A Carella, Kristin A. Shimano, Bonnie W Lau, James N. Huang, Larisa Broglie, Evan Shereck, Steven W. Allen, Timothy S. Olson, Jessica Boklan, Anupama Narla, Catherine E. McGuinn, Taizo A. Nakano, Adrianna Vlachos, Marcin W. Wlodarski, Amy E. Geddis, Nicholas J. Gloude, Jill L. O. de Jong, Anjali Sharathkumar, Jennifer A. Rothman, Akiko Shimamura, Alison A. Bertuch
Publikováno v:
American journal of hematologyREFERENCES. 96(11)
The North American Pediatric Aplastic Anemia Consortium (NAPAAC) is a group of pediatric hematologist-oncologists, hematopathologists, and bone marrow transplant physicians from 46 institutions in North America with interest and expertise in aplastic
Autor:
Michelle Poe, Beth A. Carella, Maria L. Escolar, Jessie L. Barnum, Randy M. Windreich, Xiaohua Chen, Mark Vander Lugt, Rebecca A. Marsh, Elizabeth Stenger, Paul Szabolcs, Heather Stanczak, Memphis J. Hill
Publikováno v:
Blood Adv
Children with many inherited nonmalignant disorders can be cured or their condition alleviated by hematopoietic stem cell transplantation (HSCT). Umbilical cord blood (UCB) units are a rapidly available stem cell source and offer great flexibility in
Publikováno v:
Blood. 136:3-4
Background: Dyskeratosis congenita (DC) is a rare inherited bone marrow failure syndrome, caused by telomerase dysfunction leading to shortened telomeres.1 Recent literature shows only a 23% estimated 10-year survival, secondary to death from pulmona
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S335-S336
Background Reduced intensity conditioning (RIC) transplant carries the advantage of decreased transplant related morbidity and mortality, however comes with an increased risk of viral infections, particularly cytomegalovirus (CMV) in the setting of s
Autor:
Maria L. Escolar, Hey Chong, Dennis L. Helmick, Paul Szabolcs, Beth A. Carella, Mark VanderLugt, Randy M. Windreich, Heather Stanczak, Jessie L. Barnum
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S158-S159
Objectives To evaluate engraftment, acute graft-versus-host disease (aGVHD), and overall survival of a reduced intensity conditioning regimen. Methods From 2011 to 2019, 69 patients (table 1) with nonmalignant conditions (figure 1) underwent hematopo
Autor:
Randy M. Windreich, C. Byersdorfer, Paul Szabolcs, Heather Stanczak, Albert D. Donnenberg, N. Nastasi, Linda R. Moore, Xiaohua Chen, Beth A. Carella, D. Helmick, Jessie L. Barnum
Publikováno v:
Cytotherapy. 21:e3-e4
Background & Aim Patients with primary immune-deficiency (PID) may develop pulmonary complications and at that stage most are ineligible for either lung transplant (LTX) or bone marrow transplant (BMT) alone due to futility. We are conducting a first
Publikováno v:
Blood. 132:3414-3414
Introduction: Success of umbilical cord blood transplantation (UCBT) is limited by an increased risk of graft rejection, mixed chimerism, infection, and delayed immune reconstitution. Additionally, strategies such as donor lymphocyte infusion (DLI) t